initial public offerings (IPOs) trading on American exchanges
Showing posts with label BTAI. Show all posts
Showing posts with label BTAI. Show all posts

Tuesday, October 9, 2018

BioXcel Therapeutics (BTAI) started trading on the Nasdaq on Thur 8 March 18

BioXcel Therapeutics Inc. (NASDAQ: BTAI) raised $60 million selling 5.5 million shares (upsized from 5 million) at $11 per share, the bottom of the expected range.